A pilot study of etanercept treatment for pemphigus vulgaris

Archives of Dermatology

Volumn 147, Issue 1, 2011, Pages 117-118

  Fiorentino, David F ^a   Garcia, Miki S ^b   Rehmus, Wingfield ^c   Kimball, Alexa Boer ^d  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c BC CHILDREN S HOSPITAL   (Canada)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CLOBETASOL; DEXAMETHASONE; ETANERCEPT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NYSTATIN; PLACEBO; PREDNISONE;

ARTICLE; CLINICAL ARTICLE; DRUG EFFICACY; DRUG SAFETY; ECCHYMOSIS; FEMALE; HIP FRACTURE; HUMAN; INJECTION SITE REACTION; MALE; PARESTHESIA; PEMPHIGUS VULGARIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADULT; AGED; DOUBLE-BLIND METHOD; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOLOGIC FACTORS; MALE; MIDDLE AGED; PEMPHIGUS; PILOT PROJECTS; RECEPTORS, TUMOR NECROSIS FACTOR; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 78751516696     PISSN: 0003987X     EISSN: 15383652     Source Type: Journal    
DOI: 10.1001/archdermatol.2010.409     Document Type: Article

References (5)

1. Berookhim B, Fischer HD, Weinberg JM. Treatment of recalcitrant pemphigus vulgaris with the tumor necrosis factor alpha antagonist etanercept. Cutis. 2004;74(4):245-247. (Pubitemid 39462890)
2. Lin MH, Hsu CK, Lee JY. Successful treatment of recalcitrant pemphigus vulgaris and pemphigus vegetans with etanercept and carbon dioxide laser. Arch Dermatol. 2005;141(6):680-682.
3. Shetty A, Marcum CB, Glass LF, Carter JD. Successful treatment of pemphigus vulgaris with etanercept in four patients. J Drugs Dermatol. 2009;8(10):940-943.
4. Murrell DF, Dick S, Ahmed AR, et al. Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus. J Am Acad Dermatol. 2008;58(6):1043-1046.
5. Rosenbach M, Murrell DF, Bystryn JC, et al. Reliability and convergent validity of two outcome instruments for pemphigus. J Invest Dermatol. 2009;129(10):2404-2410.